Surgical Reduction of the Inferior Turbinates for Nasal Obstruction

Exclusion Criteria

• •1. Patient has clinically significant identifiable structural deformities other than turbinate hypertrophy that may contribute to nasal or upper airway obstruction including:
• •1. Septal deviation
• •2. Concha bullosa
• •3. Enlarged adenoids or tonsils (lingual, palatine, or sphenoid)
• •4. Nasal polyps
• •5. Nasal valve collapse.
• •2. Patient has been diagnosed with obstructive sleep apnea not originating from the turbinates.
• •3. Patient has active or chronic upper airway infection that may contribute to nasal obstruction (not including chronic rhinosinusitis).
• •4. Patient has active coagulation disorder or patient is receiving anti-coagulants, which cannot be safely stopped for 14 days (7 days prior to surgery and 7 days post-surgery).
• •5. Patient has systemic disease affecting the nasal passage(e.g. Wegener's granulomatosis).
• •6. Patient is receiving or has received immunotherapy (any type) within 12 months of enrollment.
• •7. Patient has a nasal septal perforation.
• •8. Patient has had any previous turbinate surgery.
• •9. Patient has had any previous nasal surgery.
• •10. Patient has had any sinus surgery within 6 months of enrollment.
• •11. Patient has had an adenoidectomy within 3 months of enrollment.
• •12. Patient is pregnant or potentially pregnant.
• •13. Patient or caregiver is incapable of understanding or responding to the study questionnaires.
• •14. Patient is participating in another clinical study during the 12 month enrollment period.